EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
OCT 2022
TABLES
102
PAGES
158
EDITION
9
PRICE
USD 4950
CODE
MCP14356
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2023?
» Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Rat Model Market to Reach $2 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Rat Model estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 7.1% over the analysis period 2020-2027. Inbred, one of the segments analyzed in the report, is projected to record a 7.9% CAGR and reach US$644.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Outbred segment is readjusted to a revised 7.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $362.3 Million, While China is Forecast to Grow at 6% CAGR
The Rat Model market in the U.S. is estimated at US$362.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$353.4 Million by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
Knockout Segment to Record 6.5% CAGR
In the global Knockout segment, USA, Canada, Japan, China and Europe will drive the 6.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$221.7 Million in the year 2020 will reach a projected size of US$347 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
SELECT PLAYERS
Biomere; Charles River Laboratories International, Inc.; Covance, Inc.; Envigo, Inc.; Genoway S.A.; Horizon Discovery Group PLC; Janvier Labs; Taconic Biosciences, Inc.; Transposagen Biopharmaceuticals, Inc.; Transviragen, Inc.
SEGMENTS
» Rat Type (Inbred, Outbred, Knockout, Hybrid, Other Rat Types) » Technology (CRISPR, Microinjection, Nuclear Transfer, Embryonic Stem Cell Injection, Other Technologies) » Application (Research & Development , Production & Quality Control, Academics, Other Applications) » End-Use (Human, Veterinary)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Rat Model – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
Impact of Covid-19 and a Looming Global Recession |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Rat Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Rat Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Rat Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Knockout by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Knockout by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Knockout by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Outbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Outbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Outbred by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Inbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Inbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Inbred by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Immunodeficient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Immunodeficient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Immunodeficient by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Conditioned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Conditioned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Conditioned by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Cryopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Cryopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Breeding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Breeding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Breeding by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Re-Derivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Re-Derivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Re-Derivation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Quarantine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Quarantine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Quarantine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Healthcare Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Healthcare Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Healthcare Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Rat Model Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
USA Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
CANADA |
Canada Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
JAPAN |
Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Japan Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
CHINA |
Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
China Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
EUROPE |
Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
Europe Recent Past, Current & Future Analysis for Rat Model by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Rat Model by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Rat Model by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
FRANCE |
Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
France Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
GERMANY |
Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
UNITED KINGDOM |
Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
UK Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
ASIA-PACIFIC |
Rat Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2021 & 2027 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com